Acrodermatitis continua of Hallopeau with insufficient response to ixekizumab and infliximab, successfully treated with a combination of ustekinumab and tofacitinib
Authors:
- 1 April 2023
- journal article
- letter
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (2) , 182-183